Cargando…

An In-Vitro Study for Early Detection and to Distinguish Breast and Lung Malignancies Using the Pcb Technology Based Nanodosimeter

Since the early detection of cancer increases the chance of successful treatment, the present study focused to confirm the suitability of an indigenously fabricated multilayer PCB technology based 3D positive ion detector to detect breast and lung malignancy at an early stage. The 3D positive ion de...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkatraman, P., Sureka, C. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344485/
https://www.ncbi.nlm.nih.gov/pubmed/30674939
http://dx.doi.org/10.1038/s41598-018-36805-2
_version_ 1783389434451853312
author Venkatraman, P.
Sureka, C. S.
author_facet Venkatraman, P.
Sureka, C. S.
author_sort Venkatraman, P.
collection PubMed
description Since the early detection of cancer increases the chance of successful treatment, the present study focused to confirm the suitability of an indigenously fabricated multilayer PCB technology based 3D positive ion detector to detect breast and lung malignancy at an early stage. The 3D positive ion detector is a type of gas filled radiation detector works under the principle of ion induced ionization using an exempted micro curie activity source. Earlier studies report that malignant cells can be detected by analyzing the Volatile Organic Compounds (VOCs) exhaled by those cells that serve as eminent biomarkers for malignant detection. Based on this, the present study analyzed the signals produced in the detector by VOCs exhaled from 140 biopsy tissue samples that include tissue of normal and all stages of breast and lung malignancy. To strengthen the present data, the normal and advanced breast and lung malignant tissues were also analyzed using the Gas Chromatography- Mass Spectrometry (GC-MS). From this study, it is confirmed that the present 3D positive ion detector can be used to detect both breast and lung malignancy and also to distinguish them based on the variation in four basic physical parameters of the output pulse such as frequency, amplitude, rise time and fall time and four derived parameters of the pulse such as FWHM, area of the pulse, ionization cluster size, and ion drift time.
format Online
Article
Text
id pubmed-6344485
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63444852019-01-28 An In-Vitro Study for Early Detection and to Distinguish Breast and Lung Malignancies Using the Pcb Technology Based Nanodosimeter Venkatraman, P. Sureka, C. S. Sci Rep Article Since the early detection of cancer increases the chance of successful treatment, the present study focused to confirm the suitability of an indigenously fabricated multilayer PCB technology based 3D positive ion detector to detect breast and lung malignancy at an early stage. The 3D positive ion detector is a type of gas filled radiation detector works under the principle of ion induced ionization using an exempted micro curie activity source. Earlier studies report that malignant cells can be detected by analyzing the Volatile Organic Compounds (VOCs) exhaled by those cells that serve as eminent biomarkers for malignant detection. Based on this, the present study analyzed the signals produced in the detector by VOCs exhaled from 140 biopsy tissue samples that include tissue of normal and all stages of breast and lung malignancy. To strengthen the present data, the normal and advanced breast and lung malignant tissues were also analyzed using the Gas Chromatography- Mass Spectrometry (GC-MS). From this study, it is confirmed that the present 3D positive ion detector can be used to detect both breast and lung malignancy and also to distinguish them based on the variation in four basic physical parameters of the output pulse such as frequency, amplitude, rise time and fall time and four derived parameters of the pulse such as FWHM, area of the pulse, ionization cluster size, and ion drift time. Nature Publishing Group UK 2019-01-23 /pmc/articles/PMC6344485/ /pubmed/30674939 http://dx.doi.org/10.1038/s41598-018-36805-2 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Venkatraman, P.
Sureka, C. S.
An In-Vitro Study for Early Detection and to Distinguish Breast and Lung Malignancies Using the Pcb Technology Based Nanodosimeter
title An In-Vitro Study for Early Detection and to Distinguish Breast and Lung Malignancies Using the Pcb Technology Based Nanodosimeter
title_full An In-Vitro Study for Early Detection and to Distinguish Breast and Lung Malignancies Using the Pcb Technology Based Nanodosimeter
title_fullStr An In-Vitro Study for Early Detection and to Distinguish Breast and Lung Malignancies Using the Pcb Technology Based Nanodosimeter
title_full_unstemmed An In-Vitro Study for Early Detection and to Distinguish Breast and Lung Malignancies Using the Pcb Technology Based Nanodosimeter
title_short An In-Vitro Study for Early Detection and to Distinguish Breast and Lung Malignancies Using the Pcb Technology Based Nanodosimeter
title_sort in-vitro study for early detection and to distinguish breast and lung malignancies using the pcb technology based nanodosimeter
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344485/
https://www.ncbi.nlm.nih.gov/pubmed/30674939
http://dx.doi.org/10.1038/s41598-018-36805-2
work_keys_str_mv AT venkatramanp aninvitrostudyforearlydetectionandtodistinguishbreastandlungmalignanciesusingthepcbtechnologybasednanodosimeter
AT surekacs aninvitrostudyforearlydetectionandtodistinguishbreastandlungmalignanciesusingthepcbtechnologybasednanodosimeter
AT venkatramanp invitrostudyforearlydetectionandtodistinguishbreastandlungmalignanciesusingthepcbtechnologybasednanodosimeter
AT surekacs invitrostudyforearlydetectionandtodistinguishbreastandlungmalignanciesusingthepcbtechnologybasednanodosimeter